Frontier Wealth Management LLC Provention Bio, Inc. Transaction History

Frontier Wealth Management LLC

  • $8.02 Billion
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$5.66 - $8.33 $149,990 - $220,745
-26,500 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$10.12 - $19.45 $15,179 - $29,175
1,500 Added 6.0%
26,500 $278,000
Q4 2020

Feb 16, 2021
BUY
$11.79 - $18.94 $294,750 - $473,500
25,000 New
25,000 $424,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Frontier Wealth Management LLC Portfolio

Follow Frontier Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email